The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $24,388,300 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 156 grants at over 100 hospitals in 29 countries.




Ann & Robert H. Lurie Children’s Hospital of Chicago - $50,000

Amount
$50,000.00
Date
April 2015

Increased Tenascin-C (TNC) protein expression in tumor tissue and CSF in DIPG patients

Stanford University - $50,000

Amount
$50,000.00
Date
April 2015

Tumor Associated Microglia in Diffuse Intrinsic Pontine Glioma

Children's Cancer Institute - $81,683

Amount
$81,683.00
Date
February 2015

Facilitates Chromatin Transcription Complex (FACT): A novel therapeutic target against Diffuse Intrinsic Pontine Glioma.

Cincinnati Children's Hospital Medical Center - $100,000

Amount
$100,000.00
Date
February 2015

Epigenetic alterations as therapeutic targets in pediatric brain tumors

Cincinnati Children's Hospital - $176,186

Amount
$176,186.00
Date
November 2014

International DIPG Registry

University of California, San Francisco - $100,000

Amount
$100,000.00
Date
September 2014

Single-cell profiling and targeting of developmentally regulated signaling programs in DIPG.

VU University Medical Center - $30,529

Amount
$30,529.00
Date
September 2014

European DIPG Registry

Institute of Cancer Research - $95,325

Amount
$95,325.00
Date
September 2014

The evolutionary dynamics of DIPG

The Hospital of Sick Children - $99,400

Amount
$99,400.00
Date
September 2014

Development of subgroup-specific models of paediatric DIPG

Duke University Medical Center - $85,394

Amount
$85,394.00
Date
November 2013

Development of peptide vaccine for diffuse intrinsic pontine glioma

Yale University - $100,000

Amount
$100,000.00
Date
November 2013

Pre-Clinical Development of Novel DIPG Radiosensitizers

Monash Institute of Medical Research - $99,620

Amount
$99,620.00
Date
November 2013

Targeted Therapy and Stem Cell Therapy for DIPG

Cincinnati Children's Hospital - $205,000

Amount
$205,000.00
Date
November 2013

Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry

Ann and Robert H. Lurie Children's Hospital of Chicago - $100,000

Amount
$100,000.00
Date
November 2013

Ex-vivo expanded natural killer (NK) cells to target DIPG tumor cells in pre-clinical studies

The Hospital of Sick Children - $100,000

Amount
$100,000.00
Date
November 2013

Investigating Mechanisms of Therapeutic Resistance in DIPG.